HIV/AIDS: WHO earmarks N10m for condoms in Adamawa

The World Health Organisation (WHO) initiative on HIV and AIDS Control in Nigeria has earmarked N10 million for the purchase of condoms for Adamawa in 2012.

Muhammed Chibado, the Monitoring and Evaluation Officer, Adamawa State Action Community on AIDS (ASACA), made the disclosure on Wednesday in Yola.

He said the preventive materials would be distributed across the 21 local government areas of the state.

“As part of its effort to control HIV infection in Adamawa, the WHO in 2012, has approved about N10 million for the purchase of condoms,” he said.

Mr. Chibado, who expressed worry over the non-payment of counterpart fund by the state government, said the attitude was affecting the control of the disease in the state.

“The major challenge affecting the smooth control of the disease in the state is lack of counterpart fund from government.

“The community totally depends on implementing partners to carry out its primary assignment.

“Also, lack of sustainability plan as well as lack of functional and technical capacities are some of the biggest challenges so far.’’

Mr. Chibado said that effective clinical activities such as tests and provision of drugs were all funded by private partners in the state since 2002.

He called on the state government to give maximum attention to the control of the virus, so as to save the lives of thousands of its citizens, who were already positive.



PT Mag Campaign AD

Support PREMIUM TIMES' journalism of integrity and credibility

Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.

For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble endeavour.

By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.


TEXT AD: To advertise here . Call Willie +2347088095401...

BE THE FIRST TO KNOW! Subscribe to our newsletter

* indicates required


Now available on

  Premium Times Android mobile applicationPremium Times iOS mobile applicationPremium Times blackberry mobile applicationPremium Times windows mobile application

All rights reserved. This material and any other material on this platform may not be reproduced, published, broadcast, written or distributed in full or in part, without written permission from PREMIUM TIMES.